GoPath Diagnostics

March is #ColorectalCancerAwarenessMonth! Early detection saves lives. Genetic testing for Lynch syndrome & hereditary colorectal cancer can guide care & family screening. Our LYNCHNOW panel helps clinicians act fast. Learn more:geneticsnow.com/lynchnow

We'll see you in San Antonio. 🤠 Our team will be at booth 456 during the 115th Annual #USCAP Meeting! Whether you're exploring smarter solutions, need a stronger subspecialty partner, or are curious about how we support biopharma & clinical trials, we've got a lot to show you.

#PancreaticCancer is one of the deadliest cancers because it rarely shows symptoms until it's too late. By combining blood markers, researchers at UPenn developed a test that correctly identified cancer vs non-cancer cases 91.9% of the time. 🔗 nih.gov/news-events/ni……

Thank you to all who submitted abstracts and to CAPA for partnering with us on this incredible competition.

Congratulations to the winners of the 2026 @CAPA_comm x GoPath Best Abstract Award! 🏆🎉 We are so proud to celebrate the outstanding research & dedication of this year's recipients, whose work spans cutting-edge topics in spatial transcriptomics, genomics, & digital pathology.

DYK: Colorectal cancer is one of the most preventable yet often overlooked cancers. During #ColorectalCancerAwarenessMonth, we encourage convos about symptoms, screening timelines, & the importance of understanding family history. Visit @CCAlliance: colorectalcancer.org/get-involved/a…

Congratulations to all the winners! 🥳 🎉

🎊Big congratulations to the winners of our 2026 CAPA GoPath Best Abstract Award! Huge thanks to @GoPathLabs for the support and sponsorship. 🥇 Ting Zhao from MGH @MGBpathology 🥈 Mengxue Zhang from UChicago @UChicagoPath 🥈 Zhe Zhu from Columbia University @ColumbiaPathRes

Today, we recognize the strength and resilience of those living with rare diseases and the efforts driving better diagnosis, research, and care. Visit the @rarediseaseday website to learn more and see how awareness can create change. 💜 rarediseaseday.org #RareDiseaseDay

We’re counting down to #USCAP2026 in San Antonio! Learn how GoPath’s molecular & anatomic pathology expertise helps deliver smarter diagnostics & better patient outcomes. 📍 Find us at booth 456, see what’s new in our test menu and genetics solutions. #Pathology #GeneticTesting

As National Cancer Prevention Month comes to a close, we’re reminded that prevention is powerful year-round. From healthy habits to regular screenings, every step makes a difference. Continue learning and take action with the @AACR: aacr.org/patients-careg…

We are heading to San Antonio for the 115th Annual #USCAP Meeting next month! 🎯 Stop by booth 456 to see how our advanced pathology & molecular diagnostic solutions can elevate your practice. 🔗 gopathdx.com/uscap-26 #Pathology #GeneticTesting #MolecularDiagnostics

Happy Lunar New Year 🐎✨ Wishing you prosperity, good health, and momentum as we welcome the Year of the Horse in 2026. May this new year bring steady progress, strong partnerships, and new growth opportunities.🌟

How can communication help those living with hereditary cancer risk? A professor is raising awareness & research on genetic risk communication. Her work sheds light on the experiences of “previvors” & the value of support after genetic testing. usf.edu/arts-sciences/… @CASatUSF

Understanding breast self-awareness is an important part of early cancer detection. Experts say it’s about knowing how your breasts normally look & feel so you can notice changes early. Read more from the @AP: apnews.com/article/breast…

🤔DYK: Nearly 40% of cancer cases are linked to preventable causes like smoking, excess weight, and physical inactivity. 💪 During #NationalCancerPreventionMonth let’s recommit to healthier habits that lower our risk of cancer. Learn more from the @AACR: aacr.org/patients-careg…

Today, 7 in 10 people diagnosed with cancer live at least 5 years after their diagnosis. Thanks to advancements in research, treatment, & earlier detection, even late-stage cancers are undergoing improved survival rates. Read more from the @AmericanCancer cancer.org/research/acs-r…

A new GoPath study examines the HSD3B1 (1245C) allele in patients, where nearly 40% carried at least one copy & over 7% were homozygous. It outlines how genotype insights can inform expectations for ADT & long‑term hormonal strategies. 🔗 gopathdx.com/blog/tpost/f45…

What if a routine stain from your lab could change 1 in 8 prostate core diagnoses? Our new study shows that adding PIN4 to all prostate needle cores often refines initial H&E findings. See how the use of PIN4 can support confident treatment planning. 🔗: gopathdx.com/blog/tpost/f45…

A new study shows that using slide core length can shift the percent tumor involvement over 20% in the same biopsy cores. The study outlines steps to standardize slide‑based measurements & improve confidence in risk stratification. 🔗 gopathdx.com/blog/tpost/yvj…